Skip to content
Review Open access

Hypogonadism in aging men: Impact of comorbidities, diagnosis and treatment.

Sep 2026 · Maturitas · Vol 214, pp. 109124 · 0 citations · 49 references
Medicine

TL;DR

A narrative review addresses unresolved issues in diagnostic criteria, etiological assessment, and the impact of treatment on symptoms and long-term health outcomes in older men.

Abstract

Male hypogonadism is increasingly prevalent with advancing age and is particularly frequent among men with obesity, type 2 diabetes mellitus, and other cardiometabolic comorbidities (functional hypogonadism), whereas it remains relatively uncommon in younger men except in the presence of congenital or acquired disorders affecting the hypothalamic-pituitary-testicular axis (organic hypogonadism). Historically, the relationship between testosterone decline and aging per se, as well as the contribution of comorbidities, has been debated. Similarly, uncertainty has persisted regarding the management of obesity-associated functional hypogonadism, and diagnostic thresholds remain insufficiently standardized across different guidelines. Therefore, this narrative review addresses unresolved issues in diagnostic criteria, etiological assessment, and the impact of treatment on symptoms and long-term health outcomes in older men. It was based on a literature search conducted in PubMed using combinations of keywords such as obesity, testosterone, male hypogonadism, functional and organic hypogonadism, aging men, metabolic syndrome, diabetes, and comorbidities. Original research articles, systematic reviews, meta-analyses, and clinical guidelines published in English were screened, and the most relevant and high-quality publications were selected to provide a comprehensive overview of the current evidence. Additional relevant studies were identified through the reference lists of retrieved articles.

Read PDF

Similar papers

Open access Oct 2026

Late-onset Hypogonadism: Current perspective on diagnosis, management and impact on healthy aging

Late-onset hypogonadism (LOH), also termed age-related testosterone deficiency, is a clinical and biochemical syndrome affecting aging men. It is characterized by persistent hypogonadal symptoms paired with low serum testosterone levels. Unlike classical organic hypogonadism, LOH stems from a complex multifactorial mec...

T. Ferdousi · 0 citations
Open access Oct 2026

Hypogonadism in Cisgender Men Living With HIV: Prevalence, Clinical and Metabolic Features.

BACKGROUND Hypogonadism is frequently observed in men living with  human immunodeficiency virus (HIV), although its prevalence, etiology, and predictors remain incompletely understood. OBJECTIVE To evaluate the prevalence of hypogonadism and its association with metabolic factors in men living with HIV (MLWH), on sta...

F. A. Leão, Gabriel Cabreira Nunes, Manuela Almeida Ribeiro et al. · 0 citations
Open access Aug 2026

Late-Onset Hypogonadism in Male Hemodialysis Patients: Association with Statin Therapy and Cholesterol Levels.

BACKGROUND Late-onset hypogonadism (LOH), a condition characterized by age-related testosterone decline, is associated with impaired quality of life and adverse clinical outcomes. Although endocrine abnormalities are common in patients undergoing maintenance hemodialysis (MHD), the clinical characteristics and risk fac...

Hiroyuki Fujinami, T. Ando, Nobuhito Shibahara et al. · 0 citations
Review Sep 2026

PMOS beyond the reproductive years: menopause and long-term health outcomes.

Polyendocrine metabolic ovarian syndrome (PMOS) is one of the most common endocrine disorders affecting reproductive-aged women and is increasingly recognized as a lifelong condition rather than one confined to the reproductive years. As women age, some reproductive manifestations of PMOS evolve in a favorable directio...

Elena HogenEsch, H. G. Huddleston · 0 citations
Review Open access Aug 2026

Polycystic ovarian syndrome: an updated review of pathophysiology, clinical features, biomarkers, and management

Polycystic ovary syndrome (PCOS) is one of the most prevalent endocrine and metabolic disorders affecting women of reproductive age and represents a major global public health challenge. PCOS is a heterogeneous condition characterized by reproductive dysfunction, hyperandrogenism, insulin resistance (IR), and metabolic...

Blessy S. Joseph, D. B, K. Kumar · 0 citations
Review Open access Aug 2026

Bone Health and Aging in Klinefelter Syndrome.

Klinefelter syndrome (KS) is typically diagnosed in young adults, but advances in prenatal testing have led to its recognition at a much earlier age. Conversely, diagnosis in late adulthood remains uncommon, but still occurs. Independently from the age at diagnosis, KS individuals now receive more accurate and tailored...

F. Vignali, D. R. Livraghi, F. Costantino et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.